“…The daily activity of clinical nuclear medicine is, of course, driven not only by technological developments, but also by the possibility of using multiple radiopharmaceuticals in combination. For this reason, issue six highlighted the opportunities offered by the concurrent use of different radiopharmaceuticals [4].…”